Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study.

Olivier FakihMaxime DesmaretsBérenger MartinClément PratiDaniel WendlingElisabeth MonnetFrank Verhoeven

Published in: Rheumatology (Oxford, England) (2023)

MACE incidence rates at eight years are low in patients newly benefiting from LTI for AS. Our results support the hypothesis of a protective role of NSAIDs and anti-TNF in cardiovascular risk in these patients.

Keyphrases

end stage renal disease
cardiovascular events
ankylosing spondylitis
newly diagnosed
ejection fraction
chronic kidney disease
rheumatoid arthritis
peritoneal dialysis
prognostic factors
risk factors
coronary artery disease
cardiovascular disease
systemic lupus erythematosus
patient reported